from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv3627c/-

LFCtreatmentdescriptionclass of inhibitor

-0.495

Amikacinug/mL Amikacintranslation

-1.105

Cap5-10ug/mL Capreomycintranslation

-1.711

Rox10-50 ug/mL Roxithromycintranslation

-0.012

SM2-5 ug/mL Streptomycintranslation

-0.985

Tet5-10 ug/mL Tetracyclinetranslation

-0.265

Rif0.2-5ug/mL Rifampicintranscription

-0.120

Rifp0.1-0.5ug/mL Rifapentinetranscription

-1.371

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

1.328

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

0.543

CPZ10-50 ug/mL Chlorpromazinerespiration

0.436

Clofazimine10-13 ug/mL Clofaziminerespiration

-0.061

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

2.598

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

2.134

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

0.650

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

-0.027

Econazole10-24 ug/mL Econazole (azole drug)respiration

-0.392

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

0.218

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

1.008

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

-0.355

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

2.045

KCN5-20 ug/mL Potassium cyaniderespiration

0.531

NaN30.2-2 mM Sodium aziderespiration

-0.527

Nigericin50 uM Nigericinrespiration

0.624

TRC10-150 ug/mL Triclosanrespiration

0.642

TRZ10-25 ug/mL Thioridazinerespiration

-0.116

Valinomycin0.5-10 uM Valinomycinrespiration

-0.805

ZnSO42 mM ZnSO4respiration

0.966

menadione6-10 ug/mL Menadionerespiration

-0.283

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

-0.476

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

-0.570

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

-0.609

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

0.967

NRP_1Non-replicating persistence stage 1dosRassociated

-0.073

Amp0.2mg/mL AmpicillincellWall

-0.284

Cephalexin20-100 ug/mL CephalexincellWall

-0.493

Cerulenin0.32-5 ug/mL CerulenincellWall

-0.619

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

-0.596

EMB10-20 ug/mL EthambutolcellWall

-0.349

Eta12-40 ug/mL EthionamidecellWall

0.364

INH0.2-0.4 ug/mL IsoniazidcellWall

0.145

TLM0.1-0.2 mg/mL ThiolactomycincellWall

-1.269

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-1.317

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

1.259

BZA0.12 mg/mL BenzamidearomaticAmides

0.465

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

0.581

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

-0.055

H2O24 mM hydrogen peroxideDNAdamaging

-0.128

Levo10 ug/mL LevofloxacinDNAdamaging

-0.317

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

1.567

Novobiocin10 ug/mL NovobiocinDNAdamaging

0.382

Oflox5-10 ug/mL OfloxacinDNAdamaging

-0.414

UVUV-irradiationDNAdamaging

-0.355

ARP41-4 ug/mL Antitubercular compound ARP4?

-0.535

Antimycin12.5-50 ug/mL Antimycin A?

-1.020

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

-0.433

PA_110-50 ug/mL Antitubercular compound PA-1?

-0.772

PA_2110-50 ug/mL Antitubercular compound PA-21?

2.414

PA8240.2-2 ug/mL PA-824?

1.074

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

-0.225

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

-0.625

Verapamil50 uM Verapamil?

-1.040

mercaptoethanol2 mM 2-Mercaptoethanol?

-0.890

methoxatin10-20 ug/mL Methoxatin?